112 related articles for article (PubMed ID: 12385588)
41. Tc-99m MIBI uptake by a male breast lymphoma accompanied by diffuse bone marrow metastases.
Du Y; Long Y; Ma R
Clin Nucl Med; 1999 Jun; 24(6):454-5. PubMed ID: 10361949
[No Abstract] [Full Text] [Related]
42. Technetium-99m sestamibi in the diagnosis of breast cancer. The Mayagüez Medical Center experience.
Farías-Jimenez J; Rivera A; Carlo VM
Bol Asoc Med P R; 2001; 93(1-12):9-11. PubMed ID: 12755069
[TBL] [Abstract][Full Text] [Related]
43. SPECT-CT finding of (99m)Tc-HMDP uptake in abdominal adenopathies in a patient with metastasic breast cancer.
García-Talavera P; Ruiz MA; González-Selma ML; Sainz-Esteban A; Cobo A; Villanueva JG; Gamazo C; Olmos R
Rev Esp Med Nucl Imagen Mol; 2015; 34(3):203-4. PubMed ID: 25103143
[No Abstract] [Full Text] [Related]
44. Tc-99m MDP scan in medullary carcinoma of the thyroid with bone marrow invasion.
Turpin S; Villeneuve H
Clin Nucl Med; 1998 Jun; 23(6):389-90. PubMed ID: 9619333
[No Abstract] [Full Text] [Related]
45. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
46. Intense uptake of technetium-99m-MDP in primary breast adenocarcinoma with sarcomatoid metaplasia.
Pickhardt PJ; McDermott M
J Nucl Med; 1997 Apr; 38(4):528-30. PubMed ID: 9098196
[TBL] [Abstract][Full Text] [Related]
47. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
[TBL] [Abstract][Full Text] [Related]
48. Bone scintigraphy in the monitoring of treatment effect of bisphosphonates in bone metastatic breast cancer.
Chavdarova L; Piperkova E; Tsonevska A; Timcheva K; Dimitrova M
J BUON; 2006; 11(4):499-504. PubMed ID: 17309184
[TBL] [Abstract][Full Text] [Related]
49. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
Sergieva SB; Timcheva KV; Hadjiolov ND
J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
[TBL] [Abstract][Full Text] [Related]
50. Bone marrow involvement in breast cancer detected by positron emission tomography.
Lewanski CR; Kaplan GR; Potter J; Richman P; Ashford RF; Wong WL
J R Soc Med; 1999 Apr; 92(4):193-5. PubMed ID: 10450199
[No Abstract] [Full Text] [Related]
51. Accessory breast cancer.
Ohta H
Ann Nucl Med; 2003 Jul; 17(5):358. PubMed ID: 12971632
[No Abstract] [Full Text] [Related]
52. Assessment of non-small cell lung cancer viability and necrosis with three radiopharmaceuticals.
Sobic-Saranovic D; Pavlovic S; Jovanovic D; Nebojsa K; Todorovic-Tirnanic M; Subotic D; Artiko V; Obradovic V
Hell J Nucl Med; 2008; 11(1):16-20. PubMed ID: 18392221
[TBL] [Abstract][Full Text] [Related]
53. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
54. [Bone marrow scintigraphy using radiocolloids in bone metastases. Sensitivity, specificity, reliability and indications].
Fritz P; Adolph J; Bubeck B; Georgi P; zum Winkel K
Rofo; 1986 Jun; 144(6):689-95. PubMed ID: 3012705
[TBL] [Abstract][Full Text] [Related]
55. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
56. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer.
Taillefer R; Robidoux A; Turpin S; Lambert R; Cantin J; Léveillé J
J Nucl Med; 1998 Mar; 39(3):459-64. PubMed ID: 9529292
[TBL] [Abstract][Full Text] [Related]
57. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
[TBL] [Abstract][Full Text] [Related]
58. [Complementary scintigraphic examinations (99mTc-MDP, 99mTc-MIBI and Octreoscan) in breast neoplasm assessment].
Stefănescu C; Chossiere L; Rusu V; Meignan M
Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):165-8. PubMed ID: 9455458
[TBL] [Abstract][Full Text] [Related]
59. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
El-Maghraby T
Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
[TBL] [Abstract][Full Text] [Related]
60. [MR tomography and bone marrow scintigraphy in the screening of skeletal metastases in patients with breast carcinoma].
Layer G; Rieker O; Dörr D; Schnakenberg D; Steudel A; Reiser M
Rofo; 1994 May; 160(5):448-52. PubMed ID: 8173054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
